All trading involves risk. Losses can exceed deposits.

Enzon Pharmaceuticals Inc

0.36% 0.5 pts during the current or most recent trading day
Spread Bet: DFB Ways to deal
Delayed Prices
or Sign up to see live prices
Sell 137.0
Buy 137.0
Product details
or create an account to see actual figures the moment they’re released
  • Day
  • Week
  • Month
or create an account to see actual figures the moment they’re released
  • Day
  • Week
  • Month
Copyright 2015 Thomson Reuters Ltd.  Click for restrictions
Open High Low Change % Change
138 141 135 0.5 0.36

BRIEF: For the three months ended 31 March 2015, Enzon Pharmaceuticals Inc revenues decreased 41% to $5.3M. Net income decreased 16% to $7.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects other net primarily gain on sale of asse decrease from $109K (income) to $0K, General and administrative increase of 15% to $583K (expense).


Total Equity

Balance Sheet

Cash from Operating Activities

Cash Flow

Our shares technology

Start trading with IG

* If your stockbroking account is accessible under the same login as your spread betting or CFD account, you can automatically qualify for our lowest commission rate by placing at least one spread bet or CFD trade in the previous calendar month. See our full charges and fees.     

Trade shares with IG

Enjoy a £6 commission rate on UK shares when 
you add stockbroking to your existing active
IG account

Terms and condition apply*

Learn more

  1. Last hour
    No trades
  2. Today
    No trades
  3. This week
    No trades
  4. This month
    No trades


  • Global
  • United States
Market cap
Xenetic Biosciences Inc USD 53.99M
Pain Therapeutics Inc USD 80.53M
Biota Pharmaceuticals Inc USD 80.79M
Cardiome Pharma Corp USD 152.27M
Vivus Inc USD 179.60M
Peregrine Pharmaceuticals Inc USD 249.92M
SurModics Inc USD 298.61M


  • Past
  • Future
  • AUG
    Enzon Pharmaceuticals Inc Dividend For ENZN
    in 3 weeks